The drug, Liraglutide, in combination with an existing
medication, Metformin, showed a robust effect in treating type 2 diabetes
Results of a recently completed clinical trial of a
potential drug to treat Type 2 diabetes in children was announced at the Pediatric Academic Societies 2019.
Currently, only two drugs, metformin, and insulin are
approved by the U.S. Food and Drug Administration for the treatment of Type 2
diabetes. This adult diabetes medication Liraglutide, in combination with
Metformin was very effective in treating Type 2 diabetes and was well
tolerated.
Share your research, experience, and knowledge at PHARMA
MIDDLE EAST 2019 Congress on Scientific session Pharmacological Studies- https://middleeast.pharmaceuticalconferences.com/events-list/pharmacological-studies
No comments:
Post a Comment